![](/us.svg)
Trademark: 88566941
Status Date
Monday, January 23, 2023
Filing Date
Monday, August 5, 2019
Published for Opposition
Tuesday, October 22, 2019
Abandoned Date
Monday, January 23, 2023
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
The mark consists of a stylized design of a spiral.
Color is not claimed as a feature of the mark.
Jan 23, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 23, 2023
Abandonment - No Use Statement Filed
Jun 28, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 27, 2022
Sou Extension 5 Granted
Jun 16, 2022
Sou Extension 5 Filed
Jun 27, 2022
Case Assigned To Intent To Use Paralegal
Jun 16, 2022
Teas Extension Received
Dec 18, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 16, 2021
Sou Extension 4 Granted
Dec 16, 2021
Sou Extension 4 Filed
Dec 16, 2021
Teas Extension Received
Jun 11, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 9, 2021
Sou Extension 3 Granted
Jun 9, 2021
Sou Extension 3 Filed
Jun 9, 2021
Teas Extension Received
Dec 16, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 14, 2020
Sou Extension 2 Granted
Dec 14, 2020
Sou Extension 2 Filed
Dec 14, 2020
Teas Extension Received
Jun 17, 2020
Notice Of Approval Of Extension Request E-Mailed
Jun 15, 2020
Sou Extension 1 Granted
Jun 15, 2020
Sou Extension 1 Filed
Jun 15, 2020
Teas Extension Received
Dec 17, 2019
Noa E-Mailed - Sou Required From Applicant
Oct 22, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 22, 2019
Published For Opposition
Oct 2, 2019
Notification Of Notice Of Publication E-Mailed
Sep 16, 2019
Approved For Pub - Principal Register
Sep 13, 2019
Assigned To Examiner
Aug 23, 2019
Notice Of Design Search Code E-Mailed
Aug 22, 2019
New Application Office Supplied Data Entered
Aug 8, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24